These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 24387970

  • 1. Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
    Hazlewood GS, Metzler C, Tomlinson GA, Gross WL, Feldman BM, Guillevin L, Pagnoux C.
    Joint Bone Spine; 2014 Jul; 81(4):337-41. PubMed ID: 24387970
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
    Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, Hauser T, Neumann I, Tesar V, Wissing KM, Pagnoux C, Schmitt W, Jayne DR, European Vasculitis Study Group (EUVAS).
    JAMA; 2010 Dec 01; 304(21):2381-8. PubMed ID: 21060104
    [Abstract] [Full Text] [Related]

  • 3. [Diagnosis and management of small vessel vasculitides].
    Pettersson T, Karjalainen A.
    Duodecim; 2010 Dec 01; 126(12):1496-507. PubMed ID: 20617753
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Int J Clin Pharmacol Ther; 2022 Feb 01; 60(2):97-105. PubMed ID: 34622770
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.
    Tuin J, Stassen PM, Bogdan DI, Broekroelofs J, van Paassen P, Cohen Tervaert JW, Sanders JS, Stegeman CA.
    Clin J Am Soc Nephrol; 2019 Jul 05; 14(7):1021-1028. PubMed ID: 31253599
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Jul 05; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L, French Vasculitis Study Group.
    Ann Rheum Dis; 2018 Aug 05; 77(8):1150-1156. PubMed ID: 29724729
    [Abstract] [Full Text] [Related]

  • 8. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B, Lamprecht P, Gross WL.
    Curr Opin Rheumatol; 2006 Jan 05; 18(1):25-32. PubMed ID: 16344616
    [Abstract] [Full Text] [Related]

  • 9. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.
    Rheumatology (Oxford); 2017 Nov 01; 56(11):1894-1901. PubMed ID: 28977502
    [Abstract] [Full Text] [Related]

  • 10. What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
    de Groot K, Jayne D.
    Clin Nephrol; 2005 Dec 01; 64(6):480-4. PubMed ID: 16370164
    [Abstract] [Full Text] [Related]

  • 11. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.
    Nephrol Dial Transplant; 2016 Sep 01; 31(9):1453-9. PubMed ID: 27242368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne DR, European Vasculitis Study Group.
    Arthritis Rheum; 2012 Oct 01; 64(10):3472-7. PubMed ID: 22614882
    [Abstract] [Full Text] [Related]

  • 18. Necrotizing vasculitis--a 2009 update.
    Sharaf PH, Yazici Y.
    Bull NYU Hosp Jt Dis; 2009 Oct 01; 67(3):303-5. PubMed ID: 19852754
    [Abstract] [Full Text] [Related]

  • 19. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
    Lee JJY, Alsaleem A, Chiang GPK, Limenis E, Sontichai W, Yeung RSM, Akikusa J, Laxer RM.
    Pediatr Rheumatol Online J; 2019 Jun 26; 17(1):31. PubMed ID: 31242923
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.